Cetero Research Strengthens Operational Leadership.CARY, N.C. -- Cetero Research Cetero Research specializes in early clinical research and bioanalysis. Cetero provides practical solutions for Bioequivalence, Cardiac Safety, Dermatology, Bioanalytical and Labeling support studies. , an industry leader in clinical pharmacology Clinical pharmacology is the science of drugs and their clinical use. It is underpinned by the basic science of pharmacology, with added focus on the application of pharmacological principles and methods in the real world. , bioanalytical and specialty Phase II-IV CRO services, announces the promotions of Chinna Pamidi, PhD, to President of Bioanalytical Operations; Alan Copa, PharmD, to President of Clinical Operations; and Michael Murren to Chief Financial Officer (CFO See Chief Financial Officer. ). "I am very pleased to announce new senior executive appointments to Cetero's management team," said Jerry Merritt, Chief Executive Officer of Cetero. "The additions of these experts in their respective fields strengthen the leadership across our organization, with each bringing an extraordinary amount of experience with proven success in their functional roles." As President of Bioanalytical Operations, Pamidi will oversee Cetero's three bioanalytical laboratories in Houston, TX, Toronto, ON, and Fargo, ND. His primary objectives are to continue to lead the bioanalytical business by providing our customers with the highest standards of quality, rigorous standard operating procedures standard operating procedure Medtalk A technique, method or therapy performed 'by the book,' using a standard protocol meeting internally or externally defined criteria; a formal, written procedure that describes how specific lab operations are to be performed. (SOPs) and industry-leading customer service. Pamidi brings extensive bioanalytical expertise, with 15 years of focused bioanalytical method development, method validation and sample analysis. He was previously Vice President of Operations at Cetero's Toronto bioanalytical laboratory. As President of Clinical Operations, Copa will lead the overall clinical operational management and strategic direction of Cetero's six clinical pharmacology facilities. This new position will focus on enhancing Cetero's high standards in quality and study-participant safety and developing consistent policies and procedures Policies and Procedures are a set of documents that describe an organization's policies for operation and the procedures necessary to fulfill the policies. They are often initiated because of some external requirement, such as environmental compliance or other governmental across the six clinics. Dr. Copa brings extensive knowledge of Phase I especially thorough QT trials, data management, and bioanalytical operations with his 16 years of experience. He was previously President of Cetero's Fargo and East Grand Forks Grand Forks, city (1990 pop. 49,425), seat of Grand Forks co., E N.Dak., at the confluence of the Red and the Red Lake rivers; inc. 1881. In a spring wheat, livestock, and farm area, the city has grain elevators, state-operated flour mills, and plants that process facilities. As CFO, Murren will provide financial and strategic leadership for Cetero's financial operations. Murren previously worked at General Electric CO. (NYSE NYSE See: New York Stock Exchange :GE) for 16 years, most recently as chief financial officer of GE Engine Service Operations. After leaving General Electric in 2001, Murren served as chief financial officer of Hill-Rom (NYSE:HRC HRC Human Rights Campaign HRC Human Rights Council (UN) HRC Human Rights Commission HRC Hard Rock Cafe HRC Hillary Rodham Clinton (democratic senator/presidential candidate; former first lady) ) and most recently as chief financial officer of Diamond Innovations, formerly a portfolio company in the Littlejohn equity group and currently a division of Sandvik A.B. His leadership experience and track record of success providing the oversight of all financial activities, merger and acquisition activity and process improvement through six sigma Not to be confused with Sigma 6. Six Sigma is a set of practices originally developed by Motorola to systematically improve processes by eliminating defects.[1] A defect is defined as nonconformity of a product or service to its specifications. deployment will be invaluable as Cetero builds for the future. "Our clients expect the safest and highest quality research services available in the industry," stated Merritt. "Everyday, we strive to exceed our clients' expectations through customer service, strong science and quality-driven operational leadership. These additions to the senior management team will ensure consistent processes and procedures, resulting in participant safety and accurate, proven results." Cetero Research offers unparalleled expertise in clinical pharmacology and bioanalytical with a foundation of more than 25 years experience working with the biotechnology, generic and pharmaceutical industries. About Cetero Research: Cetero Research has six clinical pharmacology facilities, three bioanalytical laboratories focused on LC/MS/MS and immunochemistry Immunochemistry A discipline concerned both with the structure of antibody (immunoglobulin) molecules and with their ability to bind an apparently limitless number of diverse chemical structures (antigens); with the structure, organization, and rearrangement sample analysis and specialty Phase II-IV CRO services. Detailed company information is available at www.cetero.com, or by contacting April Johnson at 919.468.4214, or april.johnson@cetero.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion